Tetra Radar · Company Timeline

Gilead Sciences Inc (GILD)

Sector: Health Care

Earlier observations

  1. · FDA approval. The FDA approved BIXLENVO SUNLENCA STARTER PACK (COPACKAGED) for the initiation of BIXLENVO, a complete regimen for the treatment of HIV-1 infection….
  2. · FDA approval. The FDA approved BIXLENVO as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed….
  3. · FDA approval. The FDA approved HEPCLUDEX to treat chronic hepatitis delta virus infection in adults without cirrhosis or with compensated cirrhosis.

Observations from the last 30 days, with Clusters and Heat Signatures, are in the Tetra Radar Library.

Dates are event dates. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.